Windtree Therapeutics announces 1-for-50 reverse stock split effective Feb 20, 2025

WINDTREE THERAPEUTICS INC /DE/

Reverse stock split approved by stockholders on Feb 3, 2025; ratio set at 1-for-50.
Effective at 5:00 p.m. ET on Feb 20, 2025; adjusted trading begins Feb 21 under ticker WINT.
Aimed at meeting Nasdaq $1.00 minimum bid price requirement; new CUSIP: 97382D600.
Post-split outstanding shares reduced to approximately 700,000; no fractional shares issued.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/: Filed certificate of amendment to effect a 1-for-50 reverse stock split (effective 2025-02-20).

Change: charter amendment
Effective: 2025-02-20

Exact text from the filing

On February 14, 2025, Windtree Therapeutics, Inc. (the “Company”) filed a certificate of amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effectuate a 1-for-50 reverse stock split (the “Reverse Stock Split”) of the outstanding shares of the Company’s common stock (“Common Stock”).

View on SEC.gov

Browse all governance changes →

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-25-004124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.